EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Successful infliximab therapy in systemic sarcoidosis presenting with giant leg ulcers: a case based review

Nabil Belfeki, Nadia Ghariani Fetoui, Nour El Imene Ouni, Juliette Avci, Renaud Guedec-Ghelfi, Sonia Kammoun, Nouha Ghriss

Rheumatology International · 2025

DOI: 10.1007/s00296-025-05887-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Rheumatology International, 2025. Verfasst von Nabil Belfeki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Sud-Ile de France, 270 Avenue Marc Jacquet, 77000, Melun, France. nabil.b…. Hauptthemen laut MEDLINE: Infliximab, Sarcoidosis, Leg Ulcer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcoidosis is a chronic granulomatous inflammatory disease that primarily affects the lungs and skin. Cutaneous involvement occurs in approximately 30% of cases. We report herewith a rare case of a 55-year-old man with chronic, non-healing bilateral leg ulcers, ultimately diagnosed as ulcerative cutaneous sarcoidosis through histopathological confirmation. Giant leg ulcers complicating systemic sarcoidosis is rare and its management is challenging because there are no specific recommendation. In our case, a 24-month course of intravenous infliximab associated with oral prednisone induced sustained clinical remission. The current decline is three years. The aim of our work is to review the clinical presentation and management of ulcerative cutaneous sarcoidosis and compare them to reported cases in literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InfliximabSarcoidosisLeg UlcerHumansMaleMiddle AgedTreatment OutcomePrednisone

Stichwörter der Autor:innen

InfliximabLeg ulcersNoncaseating granulomasOrgan involvementSarcoidosisSkin biopsy

Substanzen

InfliximabPrednisone

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Sud-Ile de France, 270 Avenue Marc Jacquet, 77000, Melun, France. nabil.belfeki@ghsif.fr.
  • Department of Dermatology, University Hospital Farhat Hached, Sousse, Tunisia.
  • Department of Internal Medicine and Clinical Immunology, University Hospital La Pitié Salpêtrière, Paris, France.
  • EVESIO Department of Nuclear Medicine, Melun, France.
  • Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Sud-Ile de France, 270 Avenue Marc Jacquet, 77000, Melun, France.

Zitieren

APA

Belfeki, N., Ghariani Fetoui, N., Ouni, N. E. I., Avci, J., Guedec-Ghelfi, R., Kammoun, S., & Ghriss, N. (2025). Successful infliximab therapy in systemic sarcoidosis presenting with giant leg ulcers: a case based review. Rheumatology International. https://doi.org/10.1007/s00296-025-05887-3

Vancouver

Belfeki N, Ghariani Fetoui N, Ouni NEI, Avci J, Guedec-Ghelfi R, Kammoun S, et al. Successful infliximab therapy in systemic sarcoidosis presenting with giant leg ulcers: a case based review. Rheumatology International. 2025. doi:10.1007/s00296-025-05887-3

BibTeX
@article{Belfeki2025,
  author = {Belfeki, Nabil and Ghariani Fetoui, Nadia and Ouni, Nour El Imene and Avci, Juliette and Guedec-Ghelfi, Renaud and Kammoun, Sonia and Ghriss, Nouha},
  title = {Successful infliximab therapy in systemic sarcoidosis presenting with giant leg ulcers: a case based review},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-025-05887-3}
}
Kostenlos starten →